FALSE2025FY0000721371http://fasb.org/us-gaap/2025#OperatingIncomeLosshttp://fasb.org/us-gaap/2025#OperatingIncomeLosshttp://fasb.org/us-gaap/2025#GainLossOnSalesOfAssetsAndAssetImpairmentChargeshttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2025#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#DeferredTaxAndOtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#DeferredTaxAndOtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2025#InterestExpensehttp://fasb.org/us-gaap/2025#InterestExpensehttp://fasb.org/us-gaap/2025#InterestExpensehttp://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpenseiso4217:USDxbrli:sharesxbrli:pureiso4217:USDxbrli:sharescah:organizationutr:Ratecah:statescah:numberOfUSTerritoriescah:lawsuitiso4217:EURiso4217:JPYcah:segmentcah:Segmentscah:granteescah:vestingPeriods00007213712024-07-012025-06-3000007213712024-12-3100007213712025-07-310000721371cah:CVSHealthCorporationMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembercah:PharmaceuticalAndSpecialtySolutionsMember2024-07-012025-06-300000721371cah:GroupPurchasingOrganizationsMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012025-06-3000007213712025-04-012025-06-3000007213712023-07-012024-06-3000007213712022-07-012023-06-3000007213712025-06-3000007213712024-06-300000721371us-gaap:CommonStockMember2022-06-300000721371us-gaap:RetainedEarningsMember2022-06-300000721371us-gaap:TreasuryStockCommonMember2022-06-3000007213712022-06-300000721371us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000721371us-gaap:NoncontrollingInterestMember2022-06-300000721371us-gaap:NoncontrollingInterestMember2022-07-012023-06-300000721371us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012023-06-300000721371us-gaap:CommonStockMember2022-07-012023-06-300000721371us-gaap:TreasuryStockCommonMember2022-07-012023-06-300000721371us-gaap:RetainedEarningsMember2022-07-012023-06-300000721371us-gaap:CommonStockMember2023-06-300000721371us-gaap:RetainedEarningsMember2023-06-300000721371us-gaap:TreasuryStockCommonMember2023-06-3000007213712023-06-300000721371us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000721371us-gaap:NoncontrollingInterestMember2023-06-300000721371us-gaap:NoncontrollingInterestMember2023-07-012024-06-300000721371us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012024-06-300000721371us-gaap:CommonStockMember2023-07-012024-06-300000721371us-gaap:TreasuryStockCommonMember2023-07-012024-06-300000721371us-gaap:RetainedEarningsMember2023-07-012024-06-300000721371us-gaap:CommonStockMember2024-06-300000721371us-gaap:RetainedEarningsMember2024-06-300000721371us-gaap:TreasuryStockCommonMember2024-06-300000721371us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000721371us-gaap:NoncontrollingInterestMember2024-06-300000721371us-gaap:NoncontrollingInterestMember2024-07-012025-06-300000721371us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012025-06-300000721371us-gaap:CommonStockMember2024-07-012025-06-300000721371us-gaap:TreasuryStockCommonMember2024-07-012025-06-300000721371us-gaap:RetainedEarningsMember2024-07-012025-06-300000721371us-gaap:CommonStockMember2025-06-300000721371us-gaap:RetainedEarningsMember2025-06-300000721371us-gaap:TreasuryStockCommonMember2025-06-300000721371us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300000721371us-gaap:NoncontrollingInterestMember2025-06-300000721371us-gaap:AllowanceForCreditLossMember2025-06-300000721371us-gaap:AllowanceForCreditLossMember2024-06-300000721371srt:MinimumMember2024-07-012025-06-300000721371srt:MaximumMember2024-07-012025-06-300000721371us-gaap:AllowanceForLossesOnFinanceReceivablesMember2025-06-300000721371us-gaap:AllowanceForLossesOnFinanceReceivablesMember2024-06-300000721371cah:CVSHealthCorporationMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembercah:PharmaceuticalAndSpecialtySolutionsMember2023-07-012024-06-300000721371cah:CVSHealthCorporationMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembercah:PharmaceuticalAndSpecialtySolutionsMember2022-07-012023-06-300000721371cah:CVSHealthCorporationMembercah:PharmaceuticalAndSpecialtySolutionsMember2025-06-300000721371cah:CVSHealthCorporationMembercah:PharmaceuticalAndSpecialtySolutionsMember2024-06-300000721371cah:OptumRxMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembercah:PharmaceuticalAndSpecialtySolutionsMember2024-07-012025-06-300000721371cah:OptumRxMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembercah:PharmaceuticalAndSpecialtySolutionsMember2023-07-012024-06-300000721371cah:OptumRxMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembercah:PharmaceuticalAndSpecialtySolutionsMember2022-07-012023-06-300000721371cah:OptumRxMembercah:PharmaceuticalAndSpecialtySolutionsMember2025-06-300000721371cah:OptumRxMembercah:PharmaceuticalAndSpecialtySolutionsMember2024-06-300000721371cah:GroupPurchasingOrganizationsMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012024-06-300000721371cah:GroupPurchasingOrganizationsMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-07-012023-06-300000721371cah:InventoryReserveExcessAndObsoleteMember2025-06-300000721371cah:InventoryReserveExcessAndObsoleteMember2024-06-300000721371srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2025-06-300000721371srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2025-06-300000721371srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2025-06-300000721371srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2025-06-300000721371srt:MinimumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-06-300000721371srt:MaximumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-06-300000721371srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2025-06-300000721371srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2025-06-300000721371us-gaap:LandBuildingsAndImprovementsMember2025-06-300000721371us-gaap:LandBuildingsAndImprovementsMember2024-06-300000721371us-gaap:MachineryAndEquipmentMember2025-06-300000721371us-gaap:MachineryAndEquipmentMember2024-06-300000721371us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-06-300000721371us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-06-300000721371us-gaap:FurnitureAndFixturesMember2025-06-300000721371us-gaap:FurnitureAndFixturesMember2024-06-300000721371us-gaap:ConstructionInProgressMember2025-06-300000721371us-gaap:ConstructionInProgressMember2024-06-300000721371srt:MinimumMember2025-06-300000721371srt:MaximumMember2025-06-300000721371cah:GMPDMember2023-07-012024-06-300000721371cah:GMPDMember2022-07-012023-06-300000721371cah:TotalOpioidLitigationMember2022-07-012023-06-300000721371srt:MinimumMembercah:ProductLiabilityLawsuitsMember2025-06-300000721371cah:IVCApril2023AgreementMembercah:ProductLiabilityLawsuitsMember2022-07-012022-09-300000721371us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2025-06-300000721371us-gaap:PerformanceSharesMembercah:August2021Member2024-07-012025-06-300000721371us-gaap:PerformanceSharesMembercah:August2022Member2024-07-012025-06-300000721371us-gaap:PerformanceSharesMembercah:September2023Member2024-07-012025-06-300000721371us-gaap:PerformanceSharesMembercah:August2023Member2024-07-012025-06-300000721371srt:MinimumMemberus-gaap:PerformanceSharesMember2024-07-012025-06-300000721371srt:MaximumMemberus-gaap:PerformanceSharesMember2024-07-012025-06-300000721371us-gaap:ShippingAndHandlingMember2024-07-012025-06-300000721371us-gaap:ShippingAndHandlingMember2023-07-012024-06-300000721371us-gaap:ShippingAndHandlingMember2022-07-012023-06-300000721371cah:ADSMember2025-04-012025-06-300000721371cah:ADSMember2024-07-012025-06-300000721371cah:GIAMember2025-01-300000721371cah:GIAMember2025-01-012025-03-310000721371cah:UrologyAmericaMember2025-04-012025-06-300000721371cah:GIAMember2024-07-012025-06-300000721371cah:IONMember2025-04-012025-06-300000721371cah:IONMember2024-07-012025-06-300000721371cah:SpecialtyNetworksMember2024-01-012024-03-310000721371cah:SpecialtyNetworksMember2024-07-012025-06-300000721371cah:SpecialtyNetworksMember2023-07-012024-06-300000721371cah:UrologyAmericaMemberus-gaap:CustomerRelatedIntangibleAssetsMember2025-06-300000721371cah:ADSMemberus-gaap:CustomerRelatedIntangibleAssetsMember2025-06-300000721371cah:GIAMemberus-gaap:CustomerRelatedIntangibleAssetsMember2025-06-300000721371cah:IONMemberus-gaap:CustomerRelatedIntangibleAssetsMember2025-06-300000721371cah:SpecialtyNetworksMemberus-gaap:CustomerRelatedIntangibleAssetsMember2025-06-300000721371cah:UrologyAmericaMembercah:TrademarksAndPatentsMember2025-06-300000721371cah:ADSMembercah:TrademarksAndPatentsMember2025-06-300000721371cah:GIAMembercah:TrademarksAndPatentsMember2025-06-300000721371cah:IONMembercah:TrademarksAndPatentsMember2025-06-300000721371cah:SpecialtyNetworksMembercah:TrademarksAndPatentsMember2025-06-300000721371cah:UrologyAmericaMemberus-gaap:DevelopedTechnologyRightsMember2025-06-300000721371cah:ADSMemberus-gaap:DevelopedTechnologyRightsMember2025-06-300000721371cah:GIAMemberus-gaap:DevelopedTechnologyRightsMember2025-06-300000721371cah:IONMemberus-gaap:DevelopedTechnologyRightsMember2025-06-300000721371cah:SpecialtyNetworksMemberus-gaap:DevelopedTechnologyRightsMember2025-06-300000721371cah:UrologyAmericaMemberus-gaap:NoncompeteAgreementsMember2025-06-300000721371cah:ADSMemberus-gaap:NoncompeteAgreementsMember2025-06-300000721371cah:GIAMemberus-gaap:NoncompeteAgreementsMember2025-06-300000721371cah:IONMemberus-gaap:NoncompeteAgreementsMember2025-06-300000721371cah:SpecialtyNetworksMemberus-gaap:NoncompeteAgreementsMember2025-06-300000721371cah:UrologyAmericaMember2025-06-300000721371cah:ADSMember2025-06-300000721371cah:GIAMember2025-06-300000721371cah:IONMember2025-06-300000721371cah:SpecialtyNetworksMember2025-06-300000721371cah:UrologyAmericaMember2024-12-020000721371cah:ADSMember2024-12-020000721371cah:GIAMember2024-12-020000721371cah:IONMember2024-12-020000721371cah:SpecialtyNetworksMember2024-12-020000721371cah:GIAMemberus-gaap:CustomerRelatedIntangibleAssetsMembersrt:MinimumMember2025-06-300000721371cah:SpecialtyNetworksMemberus-gaap:CustomerRelatedIntangibleAssetsMembersrt:MinimumMember2025-06-300000721371cah:IONMemberus-gaap:CustomerRelatedIntangibleAssetsMembersrt:MinimumMember2025-06-300000721371cah:GIAMemberus-gaap:CustomerRelatedIntangibleAssetsMembersrt:MaximumMember2025-06-300000721371cah:IONMemberus-gaap:CustomerRelatedIntangibleAssetsMembersrt:MaximumMember2025-06-300000721371cah:SpecialtyNetworksMemberus-gaap:CustomerRelatedIntangibleAssetsMembersrt:MaximumMember2025-06-300000721371cah:GIAMembercah:TrademarksAndPatentsMembersrt:MinimumMember2025-06-300000721371cah:ADSMembercah:TrademarksAndPatentsMembersrt:MinimumMember2025-06-300000721371cah:SpecialtyNetworksMembercah:TrademarksAndPatentsMembersrt:MinimumMember2025-06-300000721371cah:IONMembercah:TrademarksAndPatentsMembersrt:MinimumMember2025-06-300000721371cah:ADSMembercah:TrademarksAndPatentsMembersrt:MaximumMember2025-06-300000721371cah:SpecialtyNetworksMembercah:TrademarksAndPatentsMembersrt:MaximumMember2025-06-300000721371cah:IONMembercah:TrademarksAndPatentsMembersrt:MaximumMember2025-06-300000721371cah:UrologyAmericaMembercah:TrademarksAndPatentsMembersrt:MaximumMember2025-06-300000721371cah:GIAMembercah:TrademarksAndPatentsMembersrt:MaximumMember2025-06-300000721371cah:UrologyAmericaMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMemberus-gaap:MeasurementInputDiscountRateMember2024-07-012025-06-300000721371cah:GIAMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMemberus-gaap:MeasurementInputDiscountRateMember2024-07-012025-06-300000721371cah:IONMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMemberus-gaap:MeasurementInputDiscountRateMember2024-07-012025-06-300000721371cah:ADSMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMemberus-gaap:MeasurementInputDiscountRateMember2024-07-012025-06-300000721371cah:SpecialtyNetworksMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMemberus-gaap:MeasurementInputDiscountRateMember2023-07-012024-06-300000721371cah:GIAMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2024-07-012025-06-300000721371cah:IONMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2024-07-012025-06-300000721371cah:ADSMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2024-07-012025-06-300000721371cah:SpecialtyNetworksMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2024-07-012025-06-300000721371cah:UrologyAmericaMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2024-07-012025-06-300000721371cah:GIACommonStockMember2024-07-012025-06-300000721371cah:TransactionDataSystemInvestmentMember2025-06-300000721371cah:OutcomesDivestitureMember2024-07-012025-06-300000721371cah:TransactionDataSystemInvestmentMemberus-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Member2023-07-100000721371us-gaap:EmployeeSeveranceMember2023-06-300000721371us-gaap:FacilityClosingMember2023-06-300000721371us-gaap:EmployeeSeveranceMember2023-07-012024-06-300000721371us-gaap:FacilityClosingMember2023-07-012024-06-300000721371us-gaap:EmployeeSeveranceMember2024-06-300000721371us-gaap:FacilityClosingMember2024-06-300000721371us-gaap:EmployeeSeveranceMember2024-07-012025-06-300000721371us-gaap:FacilityClosingMember2024-07-012025-06-300000721371us-gaap:EmployeeSeveranceMember2025-06-300000721371us-gaap:FacilityClosingMember2025-06-300000721371cah:PharmaceuticalAndSpecialtySolutionsMember2023-06-300000721371cah:GMPDMember2023-06-300000721371us-gaap:AllOtherSegmentsMember2023-06-300000721371cah:PharmaceuticalAndSpecialtySolutionsMember2023-07-012024-06-300000721371us-gaap:AllOtherSegmentsMember2023-07-012024-06-300000721371cah:PharmaceuticalAndSpecialtySolutionsMember2024-06-300000721371cah:GMPDMember2024-06-300000721371us-gaap:AllOtherSegmentsMember2024-06-300000721371cah:PharmaceuticalAndSpecialtySolutionsMember2024-07-012025-06-300000721371cah:GMPDMember2024-07-012025-06-300000721371us-gaap:AllOtherSegmentsMember2024-07-012025-06-300000721371cah:PharmaceuticalAndSpecialtySolutionsMember2025-06-300000721371cah:GMPDMember2025-06-300000721371us-gaap:AllOtherSegmentsMember2025-06-300000721371cah:GMPDMember2023-10-012023-12-310000721371cah:GMPDMember2024-04-012024-06-300000721371cah:PharmaceuticalAndSpecialtySolutionsMembercah:OutcomesDivestitureMember2024-06-300000721371cah:IPRDTrademarksandOtherMember2025-06-300000721371us-gaap:CustomerRelatedIntangibleAssetsMember2025-06-300000721371cah:TrademarksAndPatentsMember2025-06-300000721371us-gaap:DevelopedTechnologyRightsMember2025-06-300000721371us-gaap:NoncompeteAgreementsMember2025-06-300000721371cah:IPRDTrademarksandOtherMember2024-06-300000721371us-gaap:CustomerRelatedIntangibleAssetsMember2024-06-300000721371cah:TrademarksAndPatentsMember2024-06-300000721371us-gaap:DevelopedTechnologyRightsMember2024-06-300000721371cah:OperatingLeaseMember2025-06-300000721371cah:FinanceLeaseMember2025-06-300000721371cah:A3.5NotesDue2024Member2025-06-300000721371cah:A3.5NotesDue2024Member2024-06-300000721371cah:A3.75Notesdue2026Member2025-06-300000721371cah:A3.75Notesdue2026Member2024-06-300000721371cah:A4.7NotesDue2026Member2025-06-300000721371cah:A4.7NotesDue2026Member2024-06-300000721371cah:A3.41Notesdue2027Member2025-06-300000721371cah:A3.41Notesdue2027Member2024-06-300000721371cah:A5.125NotesDue2029Member2025-06-300000721371cah:A5.125NotesDue2029Member2024-06-300000721371cah:A5.0NotesDue2029Member2025-06-300000721371cah:A5.0NotesDue2029Member2024-06-300000721371cah:A5.45NotesDue2034Member2025-06-300000721371cah:A5.45NotesDue2034Member2024-06-300000721371cah:A5.35NotesDue2034Member2025-06-300000721371cah:A5.35NotesDue2034Member2024-06-300000721371cah:A4.6Notesdue2043Member2025-06-300000721371cah:A4.6Notesdue2043Member2024-06-300000721371cah:A4.5Notesdue2044Member2025-06-300000721371cah:A4.5Notesdue2044Member2024-06-300000721371cah:A4.9Notesdue2045Member2025-06-300000721371cah:A4.9Notesdue2045Member2024-06-300000721371cah:A4.368Notesdue2047Member2025-06-300000721371cah:A4.368Notesdue2047Member2024-06-300000721371cah:A5.75NotesDue2054Member2025-06-300000721371cah:A5.75NotesDue2054Member2024-06-300000721371cah:A7.0Debenturesduefiscal2027Member2025-06-300000721371cah:A7.0Debenturesduefiscal2027Member2024-06-300000721371cah:FloatingRateTermLoanDueFiscal2028Member2025-06-300000721371cah:FloatingRateTermLoanDueFiscal2028Member2024-06-300000721371cah:A4.7NotesDue2026Member2024-07-012025-06-300000721371cah:A5.0NotesDue2029Member2024-07-012025-06-300000721371cah:A5.35NotesDue2034Member2024-07-012025-06-300000721371cah:A5.75NotesDue2054Member2024-07-012025-06-300000721371cah:A3.5NotesDue2024Member2025-04-012025-06-300000721371cah:A3.079Notesdue2024Member2024-07-012025-06-300000721371cah:A5.125NotesDue2029Member2023-07-012024-06-300000721371cah:A5.45NotesDue2034Member2023-07-012024-06-300000721371us-gaap:CommercialPaperMember2025-06-300000721371us-gaap:RevolvingCreditFacilityMember2025-06-300000721371cah:A364DadRevolvingCreditFacilityMembercah:BackstopCreditFacilityMember2025-06-300000721371cah:A364DadRevolvingCreditFacilityMembercah:BackstopCreditFacilityMembersrt:ScenarioForecastMember2024-12-052025-12-040000721371cah:ShortTermCreditFacilitiesMembercah:CommittedReceivablesSalesFacilityProgramMember2025-06-300000721371cah:CreditAgreementMember2025-06-300000721371cah:CreditAgreementMember2025-04-010000721371us-gaap:BridgeLoanMember2024-11-110000721371us-gaap:LetterOfCreditMember2025-06-300000721371us-gaap:LetterOfCreditMember2024-06-300000721371cah:CommittedReceivablesSalesFacilityProgramMember2024-07-012025-06-300000721371cah:CommittedReceivablesSalesFacilityProgramMember2025-06-300000721371us-gaap:LetterOfCreditMembercah:CommittedReceivablesSalesFacilityProgramMember2024-06-300000721371us-gaap:LetterOfCreditMembercah:CommittedReceivablesSalesFacilityProgramMember2025-06-300000721371us-gaap:CommercialPaperMember2024-06-300000721371cah:CVSHealthCorporationMember2014-07-312014-07-310000721371cah:NewYorkOpioidStewardshipActMember2018-04-300000721371cah:TotalOpioidLitigationMember2025-06-300000721371cah:OpioidLawsuitsMember2024-07-012025-06-300000721371cah:TotalOpioidLitigationMember2023-07-012024-06-300000721371cah:OpioidLawsuitsMember2023-06-300000721371cah:OpioidLawsuitsMember2025-06-300000721371cah:OpioidLawsuitsMemberus-gaap:SubsequentEventMember2021-07-012025-07-310000721371cah:OpioidLawsuitsMemberus-gaap:SubsequentEventMember2025-08-012038-06-300000721371stpr:ALcah:OpioidLawsuitsMember2023-07-012024-06-300000721371stpr:ALcah:OpioidLawsuitsMember2023-11-300000721371cah:CityOfBaltimoreMembercah:OpioidLawsuitsMember2024-08-310000721371stpr:WVcah:OpioidLawsuitsMember2022-07-310000721371naics:ZZ921150cah:OpioidLawsuitsMember2022-10-310000721371cah:OpioidLawsuitsMembercah:PrivatePartiesMemberus-gaap:SubsequentEventMember2025-08-080000721371cah:OpioidLawsuitsMembercah:PrivatePartiesMembercah:ClassActionLawsuitsMemberus-gaap:SubsequentEventMember2025-08-080000721371cah:OpioidLawsuitsMembercah:PrivatePartiesMembercah:ClassActionLawsuitsMember2025-06-300000721371cah:OpioidLawsuitsMember2023-07-012024-06-300000721371cah:IVCApril2023AgreementMembercah:ProductLiabilityLawsuitsMember2023-04-302023-04-300000721371cah:IVCApril2023AgreementMembercah:ProductLiabilityLawsuitsMember2023-04-300000721371cah:IVCApril2023AgreementMembercah:ProductLiabilityLawsuitsMember2023-05-012023-09-300000721371cah:ProductLiabilityLawsuitsMember2023-07-012024-06-300000721371cah:GMPDMember2023-07-012024-06-300000721371cah:GMPDMember2022-07-012023-06-300000721371us-gaap:InternalRevenueServiceIRSMember2025-06-300000721371us-gaap:StateAndLocalJurisdictionMember2025-06-300000721371us-gaap:ForeignCountryMember2025-06-300000721371us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-06-300000721371us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-06-300000721371us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-06-300000721371us-gaap:FairValueMeasurementsRecurringMember2025-06-300000721371us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-06-300000721371us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-06-300000721371us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-06-300000721371us-gaap:FairValueMeasurementsRecurringMember2024-06-300000721371us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-06-300000721371us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-06-300000721371us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-06-300000721371us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-06-300000721371us-gaap:InterestRateSwapMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-06-300000721371us-gaap:InterestRateSwapMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-06-300000721371us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-06-300000721371us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-06-300000721371us-gaap:FairValueHedgingMember2024-07-012025-06-300000721371us-gaap:InterestRateSwapMemberus-gaap:FairValueHedgingMember2025-06-300000721371us-gaap:InterestRateSwapMemberus-gaap:FairValueHedgingMember2024-07-012025-06-300000721371us-gaap:InterestRateSwapMemberus-gaap:FairValueHedgingMember2023-07-012024-06-300000721371us-gaap:InterestRateSwapMemberus-gaap:FairValueHedgingMember2022-07-012023-06-300000721371cah:FixedRateDebtMemberus-gaap:FairValueHedgingMember2024-07-012025-06-300000721371cah:FixedRateDebtMemberus-gaap:FairValueHedgingMember2023-07-012024-06-300000721371cah:FixedRateDebtMemberus-gaap:FairValueHedgingMember2022-07-012023-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMembersrt:ScenarioForecastMemberus-gaap:SubsequentEventMember2025-07-012026-06-300000721371us-gaap:CashFlowHedgingMember2024-07-012025-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2025-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2024-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2024-07-012025-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2023-07-012024-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2022-07-012023-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2024-07-012025-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2023-07-012024-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2022-07-012023-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2024-07-012025-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2023-07-012024-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2022-07-012023-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012025-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012024-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012023-06-300000721371us-gaap:ForwardContractsMemberus-gaap:CashFlowHedgingMember2024-07-012025-06-300000721371us-gaap:ForwardContractsMemberus-gaap:CashFlowHedgingMember2023-07-012024-06-300000721371us-gaap:ForwardContractsMemberus-gaap:CashFlowHedgingMember2022-07-012023-06-300000721371us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012025-06-300000721371us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012023-06-300000721371us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012024-06-300000721371us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMembercah:February2027Memberus-gaap:NetInvestmentHedgingMember2025-06-300000721371us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMembercah:March2025Memberus-gaap:NetInvestmentHedgingMember2025-06-300000721371cah:March2025Member2024-07-012025-06-300000721371cah:June2027Memberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-06-300000721371cah:June2027Member2024-07-012025-06-300000721371us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMembercah:September2025Memberus-gaap:NetInvestmentHedgingMember2025-06-300000721371us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMembercah:June2027Memberus-gaap:NetInvestmentHedgingMember2025-06-300000721371cah:January2023Memberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-06-300000721371cah:January2023Member2024-07-012025-06-300000721371us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMembercah:September2025Memberus-gaap:NetInvestmentHedgingMember2024-06-300000721371us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMembercah:June2027Memberus-gaap:NetInvestmentHedgingMember2024-06-300000721371us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMembercah:March2025Memberus-gaap:NetInvestmentHedgingMember2024-06-300000721371us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMembercah:March2026Memberus-gaap:NetInvestmentHedgingMember2024-06-300000721371cah:March2022Memberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2024-06-300000721371cah:September2018Memberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2024-06-300000721371cah:March2022Member2024-04-012024-06-300000721371cah:September2018Member2024-04-012024-06-300000721371us-gaap:ForeignExchangeContractMember2024-07-012025-06-300000721371us-gaap:ForeignExchangeContractMember2023-07-012024-06-300000721371us-gaap:NondesignatedMember2024-07-012025-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-07-012025-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-07-012024-06-300000721371us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2022-07-012023-06-300000721371us-gaap:FairValueInputsLevel2Member2025-06-300000721371us-gaap:FairValueInputsLevel2Member2024-06-300000721371us-gaap:InterestRateSwapMemberus-gaap:FairValueHedgingMember2024-06-300000721371us-gaap:CurrencySwapMemberus-gaap:CashFlowHedgingMember2025-06-300000721371us-gaap:CurrencySwapMemberus-gaap:CashFlowHedgingMember2024-06-300000721371us-gaap:CommonClassAMember2024-06-300000721371us-gaap:CommonClassAMember2025-06-300000721371us-gaap:CommonClassBMember2025-06-300000721371us-gaap:CommonClassBMember2024-06-300000721371us-gaap:CommonClassAMember2024-07-012025-06-300000721371us-gaap:TreasuryStockCommonMember2020-07-012023-06-300000721371cah:A375MillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2024-10-012024-12-310000721371cah:A375MillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2025-01-012025-03-310000721371cah:A375MillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2024-07-012024-10-300000721371cah:A375MillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2025-01-012025-03-110000721371cah:ShareRepurchaseProgramsMember2024-07-012025-06-300000721371cah:A500MillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2023-07-012023-09-300000721371cah:A250MillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2023-07-012024-06-300000721371cah:A1BillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2023-07-012024-06-300000721371cah:A500MillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2023-07-012024-06-300000721371cah:A1BillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2022-07-012023-06-300000721371cah:A250MillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2022-07-012023-06-300000721371cah:Second250MillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2022-07-012023-06-300000721371cah:A500MillionShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2022-07-012023-06-300000721371us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-06-300000721371us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2023-06-300000721371us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-07-012024-06-300000721371us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2023-07-012024-06-300000721371us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-06-300000721371us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2024-06-300000721371us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-07-012025-06-300000721371us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2024-07-012025-06-300000721371us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-06-300000721371us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2025-06-300000721371us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-06-300000721371us-gaap:OperatingSegmentsMembercah:PharmaceuticalAndSpecialtySolutionsMember2024-07-012025-06-300000721371us-gaap:OperatingSegmentsMembercah:PharmaceuticalAndSpecialtySolutionsMember2023-07-012024-06-300000721371us-gaap:OperatingSegmentsMembercah:PharmaceuticalAndSpecialtySolutionsMember2022-07-012023-06-300000721371us-gaap:OperatingSegmentsMembercah:GMPDMember2024-07-012025-06-300000721371us-gaap:OperatingSegmentsMembercah:GMPDMember2023-07-012024-06-300000721371us-gaap:OperatingSegmentsMembercah:GMPDMember2022-07-012023-06-300000721371us-gaap:OperatingSegmentsMembercah:NuclearAndPrecisionHealthSolutionsMemberus-gaap:AllOtherSegmentsMember2024-07-012025-06-300000721371us-gaap:OperatingSegmentsMembercah:NuclearAndPrecisionHealthSolutionsMemberus-gaap:AllOtherSegmentsMember2023-07-012024-06-300000721371us-gaap:OperatingSegmentsMembercah:NuclearAndPrecisionHealthSolutionsMemberus-gaap:AllOtherSegmentsMember2022-07-012023-06-300000721371us-gaap:OperatingSegmentsMembercah:AtHomeSolutionsMemberus-gaap:AllOtherSegmentsMember2024-07-012025-06-300000721371us-gaap:OperatingSegmentsMembercah:AtHomeSolutionsMemberus-gaap:AllOtherSegmentsMember2023-07-012024-06-300000721371us-gaap:OperatingSegmentsMembercah:AtHomeSolutionsMemberus-gaap:AllOtherSegmentsMember2022-07-012023-06-300000721371us-gaap:OperatingSegmentsMembercah:OptiFreightLogisticsMemberus-gaap:AllOtherSegmentsMember2024-07-012025-06-300000721371us-gaap:OperatingSegmentsMembercah:OptiFreightLogisticsMemberus-gaap:AllOtherSegmentsMember2023-07-012024-06-300000721371us-gaap:OperatingSegmentsMembercah:OptiFreightLogisticsMemberus-gaap:AllOtherSegmentsMember2022-07-012023-06-300000721371us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2024-07-012025-06-300000721371us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2023-07-012024-06-300000721371us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2022-07-012023-06-300000721371us-gaap:OperatingSegmentsMember2024-07-012025-06-300000721371us-gaap:OperatingSegmentsMember2023-07-012024-06-300000721371us-gaap:OperatingSegmentsMember2022-07-012023-06-300000721371us-gaap:CorporateNonSegmentMember2024-07-012025-06-300000721371us-gaap:CorporateNonSegmentMember2023-07-012024-06-300000721371us-gaap:CorporateNonSegmentMember2022-07-012023-06-300000721371country:US2024-07-012025-06-300000721371country:US2023-07-012024-06-300000721371country:US2022-07-012023-06-300000721371us-gaap:NonUsMember2024-07-012025-06-300000721371us-gaap:NonUsMember2023-07-012024-06-300000721371us-gaap:NonUsMember2022-07-012023-06-300000721371us-gaap:OperatingSegmentsMembercah:PharmaceuticalAndSpecialtySolutionsMember2025-06-300000721371us-gaap:OperatingSegmentsMembercah:PharmaceuticalAndSpecialtySolutionsMember2024-06-300000721371us-gaap:OperatingSegmentsMembercah:GMPDMember2025-06-300000721371us-gaap:OperatingSegmentsMembercah:GMPDMember2024-06-300000721371us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2025-06-300000721371us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2024-06-300000721371us-gaap:CorporateNonSegmentMember2025-06-300000721371us-gaap:CorporateNonSegmentMember2024-06-300000721371country:US2025-06-300000721371country:US2024-06-300000721371us-gaap:NonUsMember2025-06-300000721371us-gaap:NonUsMember2024-06-300000721371cah:A2021LTIPMember2025-06-300000721371cah:A2021LTIPMembercah:AwardsOtherThanStockOptionsMember2025-06-300000721371cah:A2021LTIPMemberus-gaap:EmployeeStockOptionMember2025-06-300000721371us-gaap:EmployeeStockOptionMember2024-07-012025-06-300000721371us-gaap:EmployeeStockOptionMember2023-07-012024-06-300000721371us-gaap:EmployeeStockOptionMember2022-07-012023-06-300000721371us-gaap:RestrictedStockUnitsRSUMember2024-07-012025-06-300000721371us-gaap:RestrictedStockUnitsRSUMember2023-07-012024-06-300000721371us-gaap:RestrictedStockUnitsRSUMember2022-07-012023-06-300000721371us-gaap:PerformanceSharesMember2024-07-012025-06-300000721371us-gaap:PerformanceSharesMember2023-07-012024-06-300000721371us-gaap:PerformanceSharesMember2022-07-012023-06-300000721371us-gaap:RestrictedStockUnitsRSUMember2023-06-300000721371us-gaap:RestrictedStockUnitsRSUMember2024-06-300000721371us-gaap:RestrictedStockUnitsRSUMember2025-06-300000721371us-gaap:PerformanceSharesMember2023-06-300000721371us-gaap:PerformanceSharesMember2024-06-300000721371us-gaap:PerformanceSharesMember2025-06-300000721371cah:GIACommonStockMember2025-01-312025-03-310000721371cah:GIAUnitsMember2025-01-300000721371cah:GIAUnitsMember2025-01-312025-06-300000721371cah:GIAUnitsMember2025-06-300000721371cah:GIACommonStockMember2025-06-300000721371us-gaap:SubsequentEventMember2025-07-012026-06-300000721371cah:SolarisHealthLineItemsus-gaap:SubsequentEventMember2026-06-300000721371us-gaap:AllowanceForCreditLossMember2024-07-012025-06-300000721371us-gaap:AllowanceForLossesOnFinanceReceivablesMember2024-07-012025-06-300000721371us-gaap:SalesReturnsAndAllowancesMember2024-06-300000721371us-gaap:SalesReturnsAndAllowancesMember2024-07-012025-06-300000721371us-gaap:SalesReturnsAndAllowancesMember2025-06-300000721371us-gaap:AllowanceForCreditLossMember2023-06-300000721371us-gaap:AllowanceForCreditLossMember2023-07-012024-06-300000721371us-gaap:AllowanceForLossesOnFinanceReceivablesMember2023-06-300000721371us-gaap:AllowanceForLossesOnFinanceReceivablesMember2023-07-012024-06-300000721371us-gaap:SalesReturnsAndAllowancesMember2023-06-300000721371us-gaap:SalesReturnsAndAllowancesMember2023-07-012024-06-300000721371us-gaap:AllowanceForCreditLossMember2022-06-300000721371us-gaap:AllowanceForCreditLossMember2022-07-012023-06-300000721371us-gaap:AllowanceForLossesOnFinanceReceivablesMember2022-06-300000721371us-gaap:AllowanceForLossesOnFinanceReceivablesMember2022-07-012023-06-300000721371us-gaap:SalesReturnsAndAllowancesMember2022-06-300000721371us-gaap:SalesReturnsAndAllowancesMember2022-07-012023-06-300000721371cah:PricingDisputesMember2024-07-012025-06-300000721371cah:PricingDisputesMember2023-07-012024-06-300000721371us-gaap:DisputesMember2022-07-012023-06-30

2025年6月30日に終了した会計年度について

or

から＿＿＿＿への移行期間について

Commission File Number: 1-11373

登録者が証券法ルール405で定義される著名なシーズン発行体である場合は、チェックマークで示す。はい いいえ

登録者が法第13条または第15条(d)に従って報告書を提出する必要がない場合は、チェックマークで示す。はい いいえ

(1)1934年証券取引法第13条または第15条(d)により提出が義務付けられているすべての報告書を過去12ヶ月間(または登録者が当該報告書の提出を義務付けられていたより短い期間)提出したかどうか、および(2)過去90日間当該提出義務の対象であったかどうかをチェックマークで示す。はい いいえ

登録者が、過去12ヶ月間（または登録者がそのようなファイルを提出する必要があったより短い期間）に、レギュレーションS-Tのルール405（本章の§232.405）に従って提出が義務付けられているすべてのインタラクティブ・データ・ファイルを電子的に提出したかどうかをチェックマークで示す。はい

登録者が大規模加速ファイラー、加速ファイラー、非加速ファイラー、小規模報告企業、新興成長企業のいずれであるかをチェックマークで示す。取引所法の規則12b-2における「大型加速度フィラー」、「加速度フィラー」、「小規模報告企業」、「新興成長企業」の定義を参照のこと。

登録者がシェル会社（取引所法の規則12b-2に定義されている）であるかどうかをチェックマークで示す。はい ☐ いいえ

2024年12月31日現在、非関連会社が保有する議決権付株式の時価総額は以下の通りである：$28,372,319,280.

2025年7月31日現在の額面金額なしの登録者の普通株式の発行済株式数は以下のとおりである：238,793,647.

登録者の2025年定時株主総会に提出される確定委任状説明書の一部は、参照することにより、本フォーム10-Kのフォーム10-KパートIIIの要件に対応するセクションに組み込まれる。

本レポートで使用される「当社」、「当社」、「カーディナル・ヘルス」および同様の代名詞は、文脈上別段の定めがない限り、カーディナル・ヘルス・インクおよびその過半数所有子会社および連結子会社を指す。当社の会計年度は6月30日に終了します。2026年度、2025年度、2024年度、2023年度、2022年度、および2021年度という表現は、それぞれ2026年、2025年、2024年、2023年、2022年、および2021年6月30日に終了した会計年度を意味します。別段の定めがある場合を除き、本レポートに記載されている情報は2025年6月30日現在のものである。

本報告書では、連結財務データに由来する財務指標を使用していますが、米国で一般に認められた会計原則（以下「GAAP」）に従って作成された財務諸表には表示されていません。これらの指標は、米国証券取引委員会（SEC）の規則では「非GAAP財務指標」とみなされています。当社がこれらの非GAAP財務指標を使用する理由、および最も直接的に比較可能なGAAP財務指標との調整は、本レポートのMD&Aに続く「非GAAP財務指標の説明および調整」に記載されています。

このForm 10-K内のMD&Aでは、一般的に2025年度および2024年度の項目と、2025年度と2024年度の前年同期比について説明しています。このForm 10-Kに記載されていない2023年度の項目および2024年度と2023年度の前年同期比については、2024年6月30日に終了した会計年度のForm 10-K年次報告書（以下「2024年度Form 10-K」）の「経営陣による財政状態および経営成績の検討および分析」に記載されています。

本レポート（参照により組み込まれる情報を含む）には、将来の出来事や展開に左右される期待、見通し、見積もり、およびその他の事項に対応する、将来の見通しに関する記述が含まれています。将来の見通しに関する記述の多くは、MD&Aおよびリスク要因に記載されていますが、本報告書全体を通じて、「期待する」、「予想する」、「意図する」、「計画する」、「確信する」、「予定する」、「はずである」、「可能性がある」、「だろう」、「計画する」、「継続する」、「可能性が高い」などの言葉や同様の表現によって特定され、将来の業績やガイダンスを反映した記述、見通しの記述、費用の発生を含むその他の記述もあります。これらの事項にはリスクや不確実性が伴うため、実際の結果が予測、予想、または暗示されたものと大きく異なる可能性があります。これらのリスクと不確実性のうち最も重要なものは、本レポートの「リスク要因」および本レポートに含まれるForm 10-Kの別紙99.1に記載されています。本レポートに記載されている将来の見通しに関する記述は、本書の日付時点のものです。適用法で義務付けられている範囲を除き、当社はいかなる将来予想に関する記述も更新または修正する義務を負いません。

当社の年次報告書（Form 10-K）、四半期報告書（Form 10-Q）、最新報告書（Form 8-K）、およびこれらの報告書の改訂版は、当社がSECに電子的に提出した後、またはSECに提供した後、合理的に実行可能な限り速やかに、当社のウェブサイト（www.cardinalhealth.com）の「投資家情報 - 財務 - SEC提出書類」の見出しから無料で入手できます。当社ウェブサイトに含まれる、または当社ウェブサイトからアクセスできる情報は、このフォーム10-K年次報告書の一部ではなく、また参照することによりこのフォーム10-K年次報告書に組み込まれるものでもありません。SECはウェブサイト（www.sec.gov）も運営しており、年次報告書、四半期報告書、最新報告書、委任状および情報報告書、ならびに当社およびその他の公開企業に関するその他の情報を検索することができます。

カーディナル・ヘルス社は、1979年に設立されたオハイオ州の企業で、病院、医療システム、薬局、外来手術センター、臨床検査室、医院、在宅患者向けにカスタマイズされたソリューションを提供するヘルスケアサービスおよび製品のグローバル企業です。医薬品や医療用製品、医療システムとサプライチェーンの効率を高める費用対効果の高いサービスとソリューションを提供しています。患者、医療提供者、支払者、薬剤師、メーカーを結びつけ、統合されたケアコーディネーションを実現します。

当社は2つの報告セグメントで業績を報告している：医薬品・スペシャリティ・ソリューション（以下「医薬品」）セグメントとグローバル医薬品・流通（以下「GMPD」）セグメントである。報告セグメントの区分が必要なほど重要でないその他のオペレーティング・セグメントはその他に含まれており、核医学・精密医療ソリューション、アットホーム・ソリューション、オプティ・フライト®ロジスティクスで構成されています。

医薬品部門は、米国でブランド医薬品、ジェネリック医薬品、特殊医薬品、一般用医薬品、消費者向け製品を販売している。また、製薬メーカーや医療提供者に特殊医薬品に関するサービスを提供したり、病院への薬局管理サービスの提供や地域医療センター内の薬局を含む限られた数の薬局の運営、ジェネリック医薬品や一般用医薬品の再包装、専門医院向けのマネージド・サービス・オーガニゼーション・プラットフォームの提供も行っています。

アットホーム・ソリューション事業には、主に2つの事業がある：ADSを含むEdgeparkは、在宅の慢性疾患患者に医療用品を直接提供する事業であり、at-Homeは、在宅医療機器プロバイダー、在宅医療・ホスピス機関、eコマース・プロバイダーに医療用品や一般用医薬品を配送する企業間物流サービスである。

2025年度の売上高は前年度比2％減の2,226億ドルでした。これは主に医薬品セグメントOptumRxの契約満了によるものですが、既存および新規顧客からのブランド医薬品およびスペシャリティ医薬品の売上高の伸びにより一部相殺されました。

2025年度のGAAPベースの営業利益は前年度比83％増の23億ドル、非GAAPベースの営業利益は同15％増の28億ドルでした。GAAPベースの営業利益、非GAAPベースの営業利益ともに増加したのは、ブランド医薬品およびスペシャリティ医薬品の貢献の増加、MSOプラットフォームおよびADSの買収によるもので、OptumRxの契約満了により一部相殺されました。GAAPベースの営業利益の増加は、主にGMPDセグメントに関連した税引前のれん代減損費用6億7,500万ドルを含む前年度との比較によるものです。また、GAAPベースの営業利益の増加は、当社がクラスメンバーまたは原告となった反トラスト法集団訴訟における正味回収額にも好影響を受け、2025年度に1億7,100万ドルを計上しました。2025年度のGAAPベースの営業利益には、買収に伴う取引・統合費用1億6,100万ドルが含まれています。